| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | 0.098 | 0.003 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | 0.47 | 0.003 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | -0.091 | 0.004 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | -0.15 | 0.004 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | 0.089 | 0.004 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | -0.095 | 0.004 |
| mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.094 | 0.005 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.088 | 0.005 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | 0.4 | 0.006 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.006 |